VIDEO: Preventing invasive, recurrent breast cancer in postmenopausal patients
In this video, Halle Moore, MD, discussed preventive breast cancer treatments for patients who are postmenopausal and have locally excised ductal carcinoma in-situ.
The data analysis, which was presented at SABCS 2020, demonstrated similar efficacy between anastrozole and tamoxifen, but different side effect profiles, according to Moore, director of Breast Medical Oncology in the Department of Hematology and Oncology at Cleveland Clinic Taussig Cancer Institute.
“We really do have options for risk reduction in patients with ductal carcinoma in-situ,” she said. “We really should be choosing mostly based on toxicity profiles rather than efficacy of the different choices.”
Collapse
Sestak I, et al. Abstract GS2-02. Presented at: San Antonio Breast Cancer Symposium (Virtual); Dec. 8-11, 2020.